An even bigger prize may be on the horizon: a simple-to-administer yet all-encompassing blood test that would screen for every kind of known cancer in the human body even before a person showed or felt any symptoms. Bezos, Gates and others are investing hundreds of millions of dollars to make such a super-screening test a reality. If they’re successful, the market opportunity may reach $200 billion a year in sales, according to the technology’s boosters.
Read Full Article »
